Stereotaxis Shares Rise After FDA Approval for Catheter

Dow Jones

07/28

By Natalie Weger

Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter.

Shares were up 8% at $2.44 on Monday. The stock has been up 7.7% this year.

The medical technology company said its MAGiC Sweep catheter advances the technology available to diagnose and treat complex arrhythmia patients. The MAGiC Sweep would be the first robotically navigated high-density mapping catheter, the company said.

Stereotaxis said high-density mapping has transformed the electrophysiology field by enhancing cardiac ablation procedures through more precise identification of arrhythmia origin.

Write to Natalie Weger at natalie.weger@wsj.com

(END) Dow Jones Newswires

July 28, 2025 10:53 ET (14:53 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2554270770"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554270770\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554270770?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-28 22:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554270770","market":"sg","top_or_hot":-1,"title":"Stereotaxis Shares Rise After FDA Approval for Catheter","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Natalie Weger \n</p>\n<pre>\n \n</pre>\n<p>\n  Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter. \n</p>\n<p>\n  Shares were up 8% at $2.44 on Monday. The stock has been up 7.7% this year. \n</p>\n<p>\n  The medical technology company said its MAGiC Sweep catheter advances the technology available to diagnose and treat complex arrhythmia patients. The MAGiC Sweep would be the first robotically navigated high-density mapping catheter, the company said. \n</p>\n<p>\n  Stereotaxis said high-density mapping has transformed the electrophysiology field by enhancing cardiac ablation procedures through more precise identification of arrhythmia origin. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Natalie Weger at natalie.weger@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 28, 2025 10:53 ET (14:53 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stereotaxis Shares Rise After FDA Approval for Catheter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStereotaxis Shares Rise After FDA Approval for Catheter\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-07-28 22:53</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Natalie Weger \n</p>\n<pre>\n \n</pre>\n<p>\n  Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter. \n</p>\n<p>\n  Shares were up 8% at $2.44 on Monday. The stock has been up 7.7% this year. \n</p>\n<p>\n  The medical technology company said its MAGiC Sweep catheter advances the technology available to diagnose and treat complex arrhythmia patients. The MAGiC Sweep would be the first robotically navigated high-density mapping catheter, the company said. \n</p>\n<p>\n  Stereotaxis said high-density mapping has transformed the electrophysiology field by enhancing cardiac ablation procedures through more precise identification of arrhythmia origin. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Natalie Weger at natalie.weger@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 28, 2025 10:53 ET (14:53 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2554270770","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554270770","pubTimestamp":1753714380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter.Shares were up 8% at $2.44 on Monday. The stock has been up 7.7% this year.The medical technology company said its MAGiC Sweep catheter advances the technology available to diagnose and treat complex arrhythmia patients. The MAGiC Sweep would be the first robotically navigated high-density mapping catheter, the company said.Stereotaxis said high-density mapping has transformed the electrophysiology field by enhancing cardiac ablation procedures through more precise identification of arrhythmia origin.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","STXS":"Stereotaxis Ord"},"translate_title":"FDA批准导管后立体定向股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STXS":0.9},"content_text":"By Natalie Weger \n\n\n \n\n\n  Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter. \n\n\n  Shares were up 8% at $2.44 on Monday. The stock has been up 7.7% this year. \n\n\n  The medical technology company said its MAGiC Sweep catheter advances the technology available to diagnose and treat complex arrhythmia patients. The MAGiC Sweep would be the first robotically navigated high-density mapping catheter, the company said. \n\n\n  Stereotaxis said high-density mapping has transformed the electrophysiology field by enhancing cardiac ablation procedures through more precise identification of arrhythmia origin. \n\n\n \n\n\n  Write to Natalie Weger at natalie.weger@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 28, 2025 10:53 ET (14:53 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}